3D-printing of microfluidic MEMS for Lab-on-a-chip applications: M3D-Loc
The detection of a disease at an early stage increases the chance of recovery. 3D-printed lab-on-a-chip is a promising device for early diagnosis of pathologies.
This project is completed now. If interested, feel free to contact us.
3D-printing lab-on-a-chip: introduction
Microfluidic lab-on-a-chip technology, which allows the reduction of volume samples and analysis time and improves sensitivity, is a promising technology for developing efficient and portable diagnostic devices. However, the upscaling of lab-on-a-chip technology remains challenging.
3D printing facilitates the production of microfluidics devices, offering an affordable and accessible alternative to producing large amounts of labs on-chip in a reproducible way.
The M3D-LoC consortium gathers 18 industrial and academic partners from 9 countries to develop the next-generation 3D-printed microfluidic devices for diagnosis.
A pilot line combining different manufacturing techniques to produce microfluidic chips with a good resolution and a low rugosity will be built, and the performance of this new manufacturing platform will be evaluated by designing novel 3D-printed lab-on-chip devices for the detection of three diseases: tuberculosis, HIV and lung cancer.
3D-printing lab-on-a-chip: our role
In this consortium, we bring our expertise in microfluidics and lab-on-a-chip to design a microfluidic platform allowing the extraction, purification, and detection of DNA from human plasma in collaboration with biologists.
We also optimize and automatize the flow inside the 3D-printed lab-on-a-chip, thanks to the used flow control systems (valves, pressure controllers, pumps…).
This project has received funding from the European Union’s Horizon 2020 under grant agreement No 760662 (M3D-Loc project).
Image credit: Vectors designed by Freepik and vectorgraphit
